Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8
Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Language: | English |
| Published: |
2008
|
| Subjects: | |
| Online Access: | http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
my-usm-ep.29661 |
|---|---|
| record_format |
uketd_dc |
| spelling |
my-usm-ep.296612017-05-15T04:43:30Z Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8 2008-10 Abu Bakar, Ruzilawati RS Pharmacy and materia medica Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh enzim CYP3A4 dan CYP2C8. Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4 and CYP2C8 enzymes. 2008-10 Thesis http://eprints.usm.my/29661/ http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf application/pdf en public phd doctoral USM Pusat Pengajian Sains Perubatan |
| institution |
Universiti Sains Malaysia |
| collection |
USM Institutional Repository |
| language |
English |
| topic |
RS Pharmacy and materia medica |
| spellingShingle |
RS Pharmacy and materia medica Abu Bakar, Ruzilawati Population Pharmacokinetics Of Repaglinide In Healthy Subjects And Genetic Polymorphisms Of Cyp3a4 And Cyp2c8 |
| description |
Repaglinide adalah sejenis ubat pengawal glukosa prandial untuk merawat
penyakit kencing manis jenis 2. Repaglinide dimetaboliskan di dalam hepar oleh
enzim CYP3A4 dan CYP2C8.
Repaglinide is a novel prandial glucose regulator (PGR) for the treatment of
type 2 diabetes mellitus. Repaglinide is mainly metabolised in the liver by CYP3A4
and CYP2C8 enzymes.
|
| format |
Thesis |
| qualification_name |
Doctor of Philosophy (PhD.) |
| qualification_level |
Doctorate |
| author |
Abu Bakar, Ruzilawati |
| author_facet |
Abu Bakar, Ruzilawati |
| author_sort |
Abu Bakar, Ruzilawati |
| title |
Population Pharmacokinetics Of Repaglinide In
Healthy Subjects And Genetic Polymorphisms Of
Cyp3a4 And Cyp2c8 |
| title_short |
Population Pharmacokinetics Of Repaglinide In
Healthy Subjects And Genetic Polymorphisms Of
Cyp3a4 And Cyp2c8 |
| title_full |
Population Pharmacokinetics Of Repaglinide In
Healthy Subjects And Genetic Polymorphisms Of
Cyp3a4 And Cyp2c8 |
| title_fullStr |
Population Pharmacokinetics Of Repaglinide In
Healthy Subjects And Genetic Polymorphisms Of
Cyp3a4 And Cyp2c8 |
| title_full_unstemmed |
Population Pharmacokinetics Of Repaglinide In
Healthy Subjects And Genetic Polymorphisms Of
Cyp3a4 And Cyp2c8 |
| title_sort |
population pharmacokinetics of repaglinide in
healthy subjects and genetic polymorphisms of
cyp3a4 and cyp2c8 |
| granting_institution |
USM |
| granting_department |
Pusat Pengajian Sains Perubatan |
| publishDate |
2008 |
| url |
http://eprints.usm.my/29661/1/Population_pharmacokinetics_of_repaglinide_in_heal_thy_subjects_and_genetic_pol_ymorphisms_of_CYP3A4_AND_CYP2CB___________________________f.pdf |
| _version_ |
1747820187470528512 |